ABOS Acumen Pharmaceuticals, Inc.
P/E
--
Forward P/E
--
Price/Sales
538.78
Beta
0.332
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Acumen Pharmaceuticals beats third quarter 2026 EPS estimates with November Alzheimer's data readout pending
Acumen Pharmaceuticals reported a net loss of $25.4 million for the third quarter 2026, with a loss per share of $0.35 that outperformed analyst expectations....
Acumen Pharmaceuticals Inc Q3 2026 Earnings Preview: What Analysts Expect on October 26, 2026
Acumen Pharmaceuticals is expected to report zero revenue and a consensus loss of $0.43 per share, with the current stock price of $2.05 significantly trailing...